Near-diploid transitional cell carcinoma: a preliminary report

Area of Science:

• Uro-oncology
• Molecular Pathology
• Cancer Prognostics

Background:

• DNA ploidy analysis is a key prognostic factor in transitional cell carcinoma (TCC).
• Limited data exists on the clinical significance of near-diploid (ND) tumors with slightly aberrant DNA content.
• Flow cytometry (FCM) is used for DNA ploidy analysis.

Purpose of the Study:

• To investigate the clinical relevance of near-diploid (ND) tumors in TCC.
• To evaluate the relationship between DNA content, proliferation (Ki-67), EGFR expression, and clinical outcomes.
• To assess the characteristics of G0/G1 peaks in paraffin-embedded ND tumors.

Main Methods:

• Prospective study of 51 TCC cases.
• Flow cytometry (FCM) for DNA ploidy analysis (DNA index, DI).
• Ki-67 index for proliferation assessment and epidermal growth factor receptor (EGFR) expression analysis.

Main Results:

• 9.8% of TCC cases were identified as near-diploid (DI 0.92-1.14).
• ND tumors showed intermediate recurrence (60%) and cancer death (20%) rates compared to diploid and aneuploid TCC.
• Paraffin-embedded ND tumors exhibited wide G0/G1 peaks (DI 5.6-13.0) with CV > 5.5% requiring special analysis.

Conclusions:

• Near-diploid (ND) TCCs represent an intermediate prognostic group.
• Tumour proliferation (Ki-67) increases with chromosomal changes.
• Specific analytical considerations are necessary for G0/G1 peaks in paraffin-embedded urothelial carcinomas.